Last Updated: November 8, 2026

Details for New Drug Application (NDA): 089996

« Back to Dashboard

NDA 089996 describes SELENIUM SULFIDE, which is a drug marketed by Actavis Mid Atlantic, Cosette Pharms Nc, Ivax Pharms, Padagis Us, and Pharmobedient Cnsltg, and is included in five NDAs. It is available from one supplier. Additional details are available on the SELENIUM SULFIDE profile page.

The generic ingredient in SELENIUM SULFIDE is selenium sulfide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the selenium sulfide profile page.

Summary for 089996

Tradename:	SELENIUM SULFIDE
Applicant:	Padagis Us
Ingredient:	selenium sulfide
Patents:	0

Medical Subject Heading (MeSH) Categories for 089996

Antioxidants
Trace Elements

Suppliers and Packaging for NDA: 089996

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SELENIUM SULFIDE	selenium sulfide	LOTION/SHAMPOO;TOPICAL	089996	ANDA	Padagis Israel Pharmaceuticals Ltd	45802-040	45802-040-64	118 mL in 1 BOTTLE (45802-040-64)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	LOTION/SHAMPOO;TOPICAL			Strength	2.5%
Approval Date:	Jan 10, 1991	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.